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Abstract Since 1985, several research groups have shown that 
a number of amino acids in the catalytic a-subunit of Na+/K +- 
ATPase more or less strongly modulate the affinity of a digitalis 
compound like ouabain to the enzyme. However, scrutiny of these 
findings by means of chimeric Na+/K+-ATPase constructs and 
monoclonal antibodies has recently revealed that the modulatory 
effect of most of these amino acids does not at all result from 
direct interaction with ouabain, but rather originates from long- 
range effects on the properties of the digitalis binding matrix. 
Starting from this knowledge, the present review brings together 
the various pieces of evidence pointing to the conclusion that the 
interface between two interacting a-subunits in the Na+/K+-ATP - 
ase protodimer (c~/3)2 provides the cleft for inhibitory digitalis 
intercalation. 
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Na*/K+-ATPase is a complex of two catalytic ~-subunits and 
two catalytically inert fl-subunits, and a number of lipid mole- 
cules incorporated into the lipid bilayer of the plasma mem- 
brane. The cc-subunit contains about 1,012 amino acids. From 
the primary sequence, hydropathy analysis has been used to 
compute the local hydrophobicity and predict single-spanning 
s-helical segments that are long enough to traverse a 40 
membrane (approximately 20 amino acids). The most recent 
'working' model of the membrane topology of the enzyme, 
presented by Askew and Lingrel [14], comprises ten transmem- 
brane segments (H1-H10) linked by five extracellularly dis- 
posed loops. Since the membrane topology models are con- 
stantly being revised to accommodate n w findings, none of the 
defensible models (cf. Sweadner and Arystarkhova [15]) will be 
explicitly invoked here. 
2. Outcome of various attempts to identify the amino acids 
involved in the digitalis receptor site 
I. Introduction 
The Na+/K+-ATPase is the biochemical machinery in the 
Na*/K + pump. The molecular mechanism of the interconver- 
sion of scalar chemical energy of ATP and vectorial osmotic 
energy of Na+/K+-gradients over the plasma membrane as well 
as the molecular mechanism of the allosteric regulation of its 
pump power appear to be rather well understood [1 3]. Al- 
though the medicinally important role of Na+/K+-ATPase as 
the digitalis receptor (target) had already been discovered in the 
sixties [4-7], the 'microscopic' mechanism of the specific inhib- 
itory interaction of digitalis compounds with the enzyme has 
remained an open question. The major reason is the fact that 
the digitalis compounds are not competitive inhibitors, i.e. they 
do not interrupt he catalytic ycle by displacing an enzyme 
effector from its activating binding site (cf. [8]). In spite of the 
absence of distinct spatial knowledge, the digitalis receptor site 
has repeatedly been tried to compose on the basis of some 
indirect information [9-13]. As will be reviewed here, the con- 
siderations recently have turned out to be untenable and need 
substitution by a novel concept based on several lines of inde- 
pendent evidence. 
*Corresponding author. Fax: (49) (30) 949 4161. 
Abbreviations: Na+/K*-ATPase, Na+/K*-transporting adenosine tri- 
phosphate phosphohydrolase (EC 3.6.1.37); digitalis, generic name of 
steroids inhibiting Na÷/K+-ATPase by intercalation i the digitalis 
binding cleft. 
2.1. Affinity labeling by use of the p-aminobenzyldiazonio- 
derivative of ouabain 
With this reagent, he NHz-terminal peptide Mr 41,000 of the 
cc-subunit was labeled via a tryptophan residue. As the reactive 
substituent was bound to the rhamnosyl residue of ouabain, the 
digitalis binding site proper could hardly have become labeled 
by this derivative. The photochemically activatable tryptophan 
residue utilized in this labeling procedure appears to have been 
W310 of the H3 H4 loop [16]. 
2.2. Information and conclusions derived from chimeric 
constructs of Na +/K+-ATPase 
When the NH2-terminal 165 amino acid sequence of 
ouabain-resistant rat ~-subunit (including the transmembrane 
segments H 1 and H2) is replaced by a sequence from the corre- 
sponding region of ouabain-sensitive Torpedo ~-subunit, the 
resulting chimeric enzyme is ouabain-sensitive [17]. When the 
NH2-terminal amino acids M 1 to N 162 of the ouabain-resistant 
sarcoplasmic reticulum Ca2+-ATPase is replaced with the corre- 
sponding portion of ouabain-sensitive Na+/K+-ATPase s-sub- 
unit (M1 to N200), the chimeric construct shows ouabain- 
sensitivity [18]. These findings indicate that the NH2-terminal 
165 or 200 amino acids of Na*/K÷-ATPase cc-subunit are suffi- 
cient for inhibitory ouabain interaction even in an isolated 
environment. 
The above findings with the two chimeras mean that Y312, 
W314, T801 and R884, recognized as modulators of ouabain 
affinity (references in [14]) do not directly interact with digitalis 
compounds. The amino acids involved in reaction rather ap- 
pear to be located in the stretch of 165 amino acids forming the 
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NH2-terminal of the a-subunit. This knowledge also excludes 
the validity of the idea [19] that the digitalis compounds may 
intercalate themselves between the ten transmembrane s g- 
ments of one a-subunit and interfere in this way with the activ- 
ity of the enzyme. 
2.3. Observations with monoclonal antibodies 
Because of its location, the extracellularly disposed H3 H4 
loop has often been thought o be involved in digitalis binding 
via Y312 and W314 (references in [14]). The loop, however, lies 
outside the N-terminal 165 amino acid stretch recognized as at 
least partially involved in forming the digitalis binding domain 
(see above) and thus appears to be unable to directly interact 
with digitalis compounds. This conclusion is supported by the 
finding that an antibody, interacting with the region encom- 
passing H3, H4 and the H3-H4 loop, enhances rather than 
blocks ouabain binding [20]. 
The amino acids P122, D125 and N126 localized in the HI 
H2 loop have been recognized as modulators of ouabain affin- 
ity and thus supposed to serve directly in digitalis binding 
(references in [14]). Remarkebly enough, however, the mono- 
clonal antibody VG4, known to interact with the first extracel- 
lular loop, enhanced ouabain binding. If one accepts the premis 
that an antibody, which binds to residues in a ligand binding 
site, should sterically impede binding, the conclusion is that the 
H1-H2 loop is not part of the cardiac glycoside binding site 
[21]. 
2.4. Modulating effects of  amino acids" on digitalis" affinity 
As deduced above, the amino acids P 122, D 125, N 126, Y312, 
W314, T801 and R884 do not directly interact with the digitalis 
compounds. The detrimental effect on digitalis affinity arising 
from their substitution by non-equivalent amino acids (refer- 
ences in [14]) does apparently result from long-range ffects on 
the global behavior of the enzyme including delocalized struc- 
tural reorganizations. This renders topological interpretations 
difficult or impossible (cf. [22,23]). 
Most remarkably, only the amino acids C108, Y112, Q115, 
and A116 located in the high ouabain-affinity maintaining HI 
transmembrane s quence (references in [14]) appear to be able 
to interact directly with the digitalis compounds. This conclu- 
sion will be extended below to the location and structure of the 
digitalis receptor site in Na+/K+-ATPase. 
3. Corollaries of the protodimeric structure of Na/K-ATPase for 
the search on the digitalis binding matrix 
3.1. Structure of  the dimer interface 
It can be inferred from the association constant obtained for 
the self-association equilibrium 2aft = (aft)2, that the solubil- 
ized enzyme exists only as (c~fl) 2protodimer in situ and works 
in this form in the membrane [24,25]. In the ~z-fl assembly, the 
aminoacyl residues between membrane domains H7 and H8 
(possibly also from the H9-H10 domains in the carboxyl-termi- 
nal portion of c~-subunit are involved [26], while in the c~ 
dimer formation the transmembrane s gments in the amino- 
terminal portion of ~-subunit are responsible [27]. Since the 
segments H1 and H2 are associated in pairs [28], the interface 
in the dimer could be formed by four transmembrane segments. 
According to the principles of protein-protein association [29- 
31], the reduction of the water-accessible surface areas ensuing 
from monomer monomer association corresponds to large en- 
tropy losses and appreciable steric strain. Since this 'hydropho- 
bic bonding' dominates the association, relatively small contact 
areas already guarantee stability such that the assembly of 
subunits can be described as separated by clefts [31]. The non- 
polar character of the interface between the two interacting H 1 
segments results from the amino acid composition of the sub- 
unit surfaces involved in contacts. 
3.2. Observations favoring the protodimeric interface as the 
digitalis intercalating cleft 
The analysis of Na+/K+-ATPase crystals by using electron 
microscopy and computer image processing techniques showed 
that two (c~fl) protomers, contacting in their centre parts, are 
linked by a two-fold rotation axis normal to the membrane 
plane and have a contact area which is about 20 A. in height 
[32]. This roughly corresponds to the dimensions of the inter- 
face and is more than enough to accommodate a potent digitalis 
glycoside (cf. [13]). 
The following findings invite to relate the properties and 
responses of the interface cleft with the 'microscopic' mecha- 
nism of digitalis interaction with Na+/K+-ATPase. First, the 
denominator f the inhibitory digitalis action on the enzyme is 
the digitalis-elicited relaxation of negentropy strain [33] which, 
as deduced above, partially resides in the intersubunit interac- 
tion. Second, the inability of the ouabain-complexed enzyme to 
perform the reaction cycle is not because of blockade of binding 
sites for the effectors ATE Mg 2+, Na ÷ and K +, but is most likely 
due to ouabain-produced disruption of interprotomer-medi- 
ated effector site site interactions [8]. Third, the protodimeric 
enzyme shows the expected coexistence of two ATP binding 
sites but only one ouabain binding site [34,35], which is under- 
standable in the present context. Fourth, ouabain bound to 
the solubilized enzyme modifies the interface behavior such 
that the association between the two protodimers becomes 22- 
fold stronger [36]. Ouabain traps the enzyme in the tightly 
associated (afl)2 state [24]. Fifth, even the complex between 
ouabain and Na+/K+-ATPase solubilized with C~2E8 and iso- 
lated by column chromatography remains stable in the a2f12 
form [37]. Sixth, digoxin connected at the sugar side chain 
with a large protein or with Sepharose via a long polyamide or 
hydrocarbon bridge, does nevertheless inhibit Na/K-ATPase 
suggesting that the glycoside binding site is located in a cleft 
accessible from the external surface of the cell membrane (re- 
viewed in [38]). 
In conclusion, the simplest, if not the only tenable, explana- 
tion for the above observations i that one digitalis molecule 
intercalates itself in the interprotomeric cleft of a Na+/K+-ATP - 
ase molecule that thus serves as digitalis receptor-site. 
4. Perspective 
Knowledge on the location and amino acid composition of 
the digitalis receptor site is urgently required for the prediction 
of 3D structure of the peptide sequences enveloping a digitalis 
molecule, and for composing an operative model of the binding 
site capable of predicting the binding affinity of designed com- 
pounds prior to synthesis (cf. [39,40]). 
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